Prof. Hussein Y. Naim
Affiliation:
• General Manager, Vaccinum® – Life Sciences and Vaccines Consulting (Lyss, Switzerland)
• Former Group Leader, Institute of Molecular Biology / Department of Molecular Life Sciences, University of Zurich
• General Manager, Vaccinum® – Life Sciences and Vaccines Consulting (Lyss, Switzerland)
• Former Group Leader, Institute of Molecular Biology / Department of Molecular Life Sciences, University of Zurich
Viral vectors Vaccine development Translational biotechnology
Top 3 Highlights:
- Pioneered viral-vector vaccine technology — Led one of the first programs to create a genetically engineered live-attenuated recombinant virus vector and successfully transferred this technology (with hands-on training) to partners in Europe and the United States.
- Directed industrial vaccine R&D — Served as Director of Vaccine Research at Berna Biotech and Crucell in Switzerland, driving development of novel vaccines and translational platforms from lab to clinic.
- Global expert for health and regulatory authorities — Secured competitive EU and NIH grants and served on review and advisory boards for WHO, EU bodies, and Swiss medical authorities, shaping international policy on vaccines, biosafet,y and biotechnology.
